CRODA INTERNATIONAL ORD 10. – Consensus Indicates Potential -28.0% Downside

Broker Ratings
[shareaholic app="share_buttons" id_name="post_below_content"]

CRODA INTERNATIONAL ORD 10. found using the EPIC (LON:CRDA) now have 17 analysts covering the company. The range between the high target price and low target price is between £55.00 and £39. so the average target price would be £50.17. With the shares previous close at £69.70 this would imply there is a potential downside of -28.0%. There is a 50 day moving average of £68.01 and the 200 day MA is £64.82. The market capitalisation for the company is £10b. Find out more information at: http://www.croda.com

Croda International creates, makes, and sells specialty chemicals in Europe, the Middle East, Africa, North America, Asia, and Latin America. The company operates in four segments: Personal Care, Life Sciences, Performance Technologies, and Industrial Chemicals. It offers adhesives; crop protection additives and adjuvants, seed enhancement and animal health chemicals, chemical bio-stimulants, and specialty additives for agricultural films; and lubricant additives, coatings and polymers, vehicle cleaning chemicals, and products for automotive textiles and fibers, as well as specialty additives for plastics, and battery and catalyst industries. The company also provides specialty ingredients for self-tanning, color cosmetics, bath and shower, deodorants, anti-perspirants, depilatories, men’s grooming, and oral hygiene, as well as skin, hair, sun, body, and baby care applications; construction chemicals and bitumen additives; dietary supplements; and advanced materials, and polymer additives for electronics and devices. In addition, it offers chemistries, emulsifiers, fuel and power generation additives, and polymer additives; food additives; specialty polymer additives for furniture and wood applications; household, industrial, and institutional cleaning products; lubricants; oleochemicals; and packaging, print, and paper chemicals. Further, the company provides paints and coatings; active pharmaceutical ingredients; thermal management products; plastic and rubber products; skin health products; hygiene and industrial nonwovens, botanical extracts, tissues, and textile auxiliaries; and water treatment chemicals. Additionally, it offers bio-based phase change materials for buildings and ventilation, clothing and healthcare, electronics and devices, food and refrigeration, energy storage and recovery, temperature controlled packaging, and vehicles and automotive applications. The company was incorporated in 1925 and is headquartered in Goole, the United Kingdom.

Twitter
LinkedIn
Facebook
Email
Reddit
Telegram
WhatsApp
Pocket
Find more news, interviews, share price & company profile here for:
    Croda International Plc's Q3 2024 sales rose to £407m, up 5% year-on-year. Despite currency challenges, full-year profit outlook remains steady.
    Croda International Plc appoints Stephen Oxley as Chief Financial Officer, bringing his extensive experience from Johnson Matthey and nearly 30 years at KPMG.
    Croda International Plc (LON:CRDA) appoints Ian Bull as Non-Executive Director effective 25 June 2024, bringing vast financial and board experience.

      Search

      Search